Public Calendar: January 27 - February 2, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 01/28/2019
Location: Washington, DC
Subject: Advancing the Generation and Use of Real-World Evidence for Regulatory and Value-Based Payment Decision-Making
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Academia, government, industry, media, and other invited guests
Event Date: 01/29/2019
Location: Silver Spring, MD
Subject: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Workshop
FDA Participant/Group: Several FDA senior officials and staff members
Non FDA Participant/Group: Industry, government, media, patients, and other registered guests
Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operation, CDER
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 01/31/2019
Location: College Park, MD
Subject: Produce Industry Meeting
FDA Participant/Group: SUSAN MAYNE; JENNIFER THOMAS; CATHERINE MCDERMOTT; KARI BARRETT; MICHAEL MAHOVIC; KARI IRVIN; JOANN GIVENS; JAMES GORNY; STEVEN MUSSER; JAN CARLSON; SAMIR ASSAR; DOUGLAS STEARN; DAVID GOLDMAN; JEFFREY FARRAR; WILLIAM CORRELL; ORVILLE HARRIS; REBECCA BUCKNER; MICHAEL ROGERS; LEANNE SKELTON; BARBARA CASSENS;
Non FDA Participant/Group: Several members of the romaine task force
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 01/31/2019
Location: Silver Spring, MD
Subject: Medical Devices: Collaborative Community Efforts
FDA Participant/Group: WILLIAM MAISEL; JOSHUA SILVERSTEIN;
Non FDA Participant/Group: Andrew Coats, Dave Francoeur, Larry Hertzler, Rick Staab, Scott Nuedelman, Scott Trevino, Shelia O'Donnell, Tim McGeath (Alliance for Quality Medical Device Servicing);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event